Published date: 17 August 2023

This notice was replaced on 15 September 2023

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 25 June 2024)

Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.


Contract summary

Industry

  • Peptones and protein substances - 24956000

  • Research services - 73110000

Location of contract

United Kingdom

Value of contract

£8,000,000

Procurement reference

GSS23564

Published date

17 August 2023

Approach to market date

31 August 2023

Contract start date

1 December 2023

Contract end date

30 November 2027

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes


Description

*** For the avoidance of doubt, this is not a call for competition, this notice is to inform the market of a Future Opportunity***

UK Research and Innovation (UKRI) brings together the seven Research Councils (AHRC, BBSRC, EPSRC, ESRC, MRC, NERC, STFC) plus Innovate UK and a new organisation, Research England.

UKRI wishes to establish a Framework for the provision of Oligonucleotide Synthesis and DNA Sequencing Services.

The Framework will be based upon four LOTS

LOT 1 - DNA Sequencing Services
LOT 2 - Custom Gene Synthesis
LOT 3 - Advanced DNA Service
LOT 4 - Custom Oligonucleotides

This Framework will be made accessible for UKRI and it is intended that multiple providers will be appointed for each of the LOTS.

The objective of this procurement will be to:

a) Produce a Framework Agreement that UKRI can easily use and provide a compliant route to market.

b) Capture a large percentage of the Oligonucleotide Synthesis and DNA Sequencing requirements from large value items to low value, high volume items.

c) Develop strong relationships with UKRI and Suppliers to ensure that the requirements are captured and value for money is achieved.

d) To capture quality management information that will support informed decision making in future procurements.

e) To ensure sustainability aspects are considered and integrated into the Framework Agreement.

f) To continuously improve and apply best practice procurement that meets the end users' requirements.

There is no commitment at this stage that the above mentioned opportunity will proceed in its current format however, at this stage and subject to the relevant approvals this is the intention.


More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2023/2024 £2,000,000
2024/2025 £2,000,000
2025/2026 £2,000,000
2026/2027 £2,000,000

Attachments

Additional text

****For the avoidance of doubt, this Expression of Interest is NOT a Call for Competition****

The Expression of Interest is being issued to understand interest with regards to the current view of the requirements detailed.

****It is to be noted that there is no commitment at this stage****

If you believe this will be of interest to your organisation, please register your interest by sending an email to coreservices@uksbs.co.uk ensuring that the subject heading includes the following: GSS23564 - Expression of Interest no later than 12:00hrs GMT on Thursday 24th August 2023.

Please advise if there is any saliant information you believe that needs to be considered further before any formal competition is launched.

Any information supplied shall not place any supplier at an advantage in a potential procurement process.


About the buyer

Contact name

Goods and Self Serve

Address

UK Shared Business Services, Polaris House,North Star Avenue
SWINDON
SN2 1FF
England

Telephone

01793 867005

Email

coreservices@uksbs.co.uk